2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$5.88+$0.01 (+0.26%)
Price as of Jul 13, 2026 7:10 PM EDT- $550.6MMarket Cap
- 12.26%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$5.88+$0.01 (+0.26%)
MYGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.86 | ||
Change | +$0.03 (+0.51%) | ||
Open | $5.82 | ||
High | $6.01 | ||
Low | $5.67 | ||
Previous Close | $5.83 | ||
Volume | 811,599 | ||
30-Day Average Volume | 1,584,502 | ||
1-Week Change | -2.82% | ||
1-Month Change | 35.33% | ||
1-Year Change | 12.26% | ||
3-Year Change | -74.34% | ||
5-Year Change | -82.22% | ||
Fundamentals | |||
Shares Outstanding | 94.4M | ||
Total Assets | $673.7M | ||
Market Cap | $550.6M | ||
Enterprise Value | $546.5M | ||
Period: QTR TTM FY | |||
Revenue | $200.4M | ||
Net Income | -$34.1M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$34.1M | ||
EBITDA | -$21.6M | ||
Net Working Capital | $182.6M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 03/26/2009 | ||
Earnings & Revenue